Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000600609 | SCV000713608 | benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | p.Asn109Asn in exon 2 of SLITRK6: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 3.06% (300/9794) o f African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs35119660). |
Gene |
RCV000600609 | SCV000717216 | benign | not specified | 2017-11-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000993088 | SCV001145819 | benign | not provided | 2019-07-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000993088 | SCV002335187 | benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000993088 | SCV005230972 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003980127 | SCV004788404 | benign | SLITRK6-related disorder | 2019-07-15 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |